What Is Alexander Green’s #1 AI Stock? (Revealed)

The Oxford Club’s Alexander Green has released a new (September 2023) presentation about what he believes is the “#1 AI stock.”

In the presentation, Alex Green says that the company he’s teasing could become the “most important AI company in the world” in the years ahead.

And in the process, make lots of money for those who invest in it.

What’s his pick?

Alex Green didn’t reveal the company name in the presentation because he wants us to join his $49 newsletter called The Oxford Communique to find out.

However, he did share some hints about it.

And based on those clues, I think I know what AI stock he is teasing.

Read on to learn more.

Breaking Down Alex Green’s AI Stock Teaser

The core theme in Alex Green’s presentation is that ONE stock could make you rich, and he suggests that the AI company he’s recommending has that kind of potential.

To add credibility to this claim… Green shared the story of a “Kansas Welder” named Stewart, who apparently read an investment book that led him to buy over 5,800 shares of Berkshire Hathaway at less than $500 a share and eventually become a billionaire.

Long story short, Green says he’s found a stock with that same kind of potential…

“Tens of thousands of Americans have become millionaires thanks to just one stock.

“It happens ALL THE TIME.”

[…]

“Imagine buying one single stock in the next three hours… and changing the trajectory of your family’s future forever.”

[…]

“How do we go about identifying the stock with the best chance to get us there?

“That’s what I’m going to share with you today.

“You see… I’ve found the next stock that I believe has just as much potential as (perhaps more than) Berkshire Hathaway, Apple, Netflix or Amazon.”

Source: https://web.archive.org/web/20231025003856/https://pro.oxfordclubcommunique.com/p/PLAN1023UPTO99OXFLT2YRDSOMT/NOXFZA26

Alex Green has made similar claims about being able to retire on a single stock before, and it’s a bit hyperbolic, so I would recommend taking his claims with a pinch of salt.

It may be possible to get rich off of one stock, but this is very rare.

Most successful investors didn’t get rich by finding some magical “little-known” stock. They learned how to invest properly and develop a sound long-term strategy.

In any case, here’s what Alex Green said about his pick (emphasis mine):

“The company I’m going to tell you about today I believe will become the most important AI company in the world over the coming years.

“It’s currently a small company – with a market cap of less than $1 billion. And a stock price under $10.”

Why is he so bullish on this AI company?

According to Green, not only is it developing a product that can help “virtually every single person on the planet,” but it’s the “perfect stock.”

“Because the company is in the process of developing a product that will help virtually every single person on the planet.

“The market they are targeting is worth approximately $12 trillion globally.”

[…]

“We’re looking at the potential for billions of dollars in future sales!

“In short, if you want to find that one winning stock – just like Stewart from Kansas – this company meets every metric you could want in a Perfect Stock.

“And most astonishing of all, it trades for less than $10 today…”

What does the company do?

According to Green, it’s a medical technology company that has invented the “world’s first AI-designed drug to enter clinical trials.” And he believes it will ‘lead the charge’ of revolutionizing the entire pharmaceutical industry.

“The company I’m telling you about today is the first AI platform to improve treatment outcomes for cancer patients.

“It is the inventor of the world’s first AI-designed drug to enter clinical trials.”

[…]

“In fact, I believe it [AI] will completely revolutionize the entire pharmaceutical industry… with this one company leading the charge.”

So, long story short, Alex Green is bullish on the convergence of artificial intelligence and the pharmaceutical industry, and he believes he’s found the #1 stock in this space.

“… in the future, it could become the most valuable AI company in the world.

“I believe it is the #1 AI Stock.”

What company is he referring to?

Read on!

What Is Alex Green’s #1 AI Stock Pick?

Based on the clues we’ve discussed so far, Alex Green is teasing a company that is leveraging AI to develop drugs for cancer patients. He also said it has a market cap of less than $1 billion and that its stock is trading for under $10 a share.

What other clues did he share?

One other clue Alex Green shared was that the company was founded in England by a doctor in biophysics from the University of Oxford.

“It is also a medical technology company… founded in England by a doctor in biophysics from the University of Oxford.”

He also discussed partnerships the company has with several well-known pharmaceutical companies, including Sanofi, Merck, and Bristol Myers Squibb (among others).

“Sanofi recently agreed to pay the company up to $5.2 billion to develop 15 experimental oncology and immunology drugs.”

[…]

“And that’s just one of many projects in the works. The latest is a collaboration with Merck on three potential best-in-class drug targets. The deal could be worth up to $674 million.”

[…]

“It’s also signed a major $1.2 billion partnership with Bristol Myers Squibb, one of the biggest pharmaceutical companies in the world.”

And he dropped what is easily the most tangible clue of all, a quote from the President of a different company called Apeiron Therapeutics:

Green shared numerous other hints, too.

For example, he talked about treatments the company is working on, other partnerships it has in place, its facilities, and more.

But the above clues were more than enough to solve this one.

So, what’s his pick?

It looks like Alex Green is teasing Exscientia (EXAI), a UK-based “pharmatech” company that uses AI as part of its drug discovery process.

Here’s how the company describes itself:

“Founded in 2012, we are leading the development of a new discipline; pharmatech, which is at the interface of advanced AI application and complex drug discovery.”

Source: https://www.exscientia.ai/our-mission

And here’s an overview of why I think Exscientia is a match:

• It is an AI drug discovery company based in the UK.
• The clues Alex Green shared about the company’s founder appear to line up with Exscientia’s founder and CEO, Andrew Hopkins.
• This press release discusses some of the partnerships Exscientia has in place, which appear to include the companies Alex Green mentioned (above).
• The quote Green shared (see above) lines up with a quote from the President of GT Apeiron Therapeutics about Exscientia, as per this page on businesswire.com.
• The company has a market cap of around $713 million and a share price of “under $10” as of October 24, 2023.

So, Exscientia looks like a match here.

If you want to know for certain, you’d need to read the report Alex Green has put together called “The #1 AI Stock: How to Retire on This Obscure Under-$10 Stock.”

But the only way to get your hands on that report is to join Alex Geen’s newsletter, The Oxford Communique, for $49.

Is it a decent newsletter?

You do have to contend with some upsells/annoying marketing, and not everything Alex Green recommends has worked out, but it’s not bad for the price.

Basically, you get a monthly newsletter with recommendations and investment insights from Alex Green, along with research reports he’s put together on different stocks.

I know this because I joined it myself a while back, and you can see my full review of it here if you want my complete thoughts on it.

Bottom Line

Alex Green’s latest teaser centers around AI, how he thinks AI is revolutionizing the pharmaceutical space, and the company he believes is “leading the charge.”

I have no idea if the company he’s recommending is a good investment or not, let alone if it will be in the same league as the likes of Berkshire Hathaway, Netflix, and Amazon.

However, I do know that the vast majority of stocks never perform that well and that predicting which ones have the kind of upside potential is extremely difficult.

This is why you should never invest more than you can afford to lose. Because no one knows what companies will do well in the future, even if they’ve made some decent calls in the past.

Anyway, I hope you found this article helpful. Assuming you agree with my research, at least now you don’t have to rush out and spend $49 to find out the name of the company.

Thanks for reading, and all the best going forward!